July/August 2017

New Payment And Financing Models For Curative Regenerative Medicines

In Vivo
Michael J. Werner

Partner Michael Werner sheds some light on what the next decade holds in store for curative gene and cell therapy products, and what these new innovative products may be able to do for patients with costly diseases.

READ: New Payment And Financing Models For Curative Regenerative Medicines

Related Insights